Oscar Health (NYSE:OSCR) Earns "Neutral" Rating from Piper Sandler

Oscar Health (NYSE:OSCR - Get Free Report)'s stock had its "neutral" rating restated by equities researchers at Piper Sandler in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. They presently have a $14.00 target price on the stock. Piper Sandler's price target suggests a potential downside of 7.70% from the stock's current price.

Other analysts have also recently issued research reports about the stock. Wall Street Zen cut shares of Oscar Health from a "buy" rating to a "hold" rating in a research note on Sunday, June 8th. Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and reduced their price target for the company from $16.00 to $10.00 in a research report on Friday. Barclays initiated coverage on Oscar Health in a research report on Wednesday, July 2nd. They set an "underweight" rating and a $17.00 price objective for the company. Finally, Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Four analysts have rated the stock with a sell rating and four have assigned a hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $14.92.

Oscar Health Trading Up 5.5%

Oscar Health stock traded up $0.79 during trading hours on Monday, hitting $15.17. The stock had a trading volume of 31,945,244 shares, compared to its average volume of 10,310,604. The business's 50 day simple moving average is $16.30 and its 200-day simple moving average is $14.89. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The stock has a market cap of $3.86 billion, a price-to-earnings ratio of 54.17 and a beta of 1.90. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The business had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. During the same quarter last year, the business earned $0.62 EPS. The firm's quarterly revenue was up 42.2% on a year-over-year basis. On average, equities analysts predict that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director owned 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 25.11% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in the business. Southeastern Asset Management Inc. TN grew its position in shares of Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after buying an additional 1,073,359 shares during the period. Jacobs Levy Equity Management Inc. grew its holdings in Oscar Health by 37.8% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock worth $23,403,000 after purchasing an additional 477,634 shares during the period. Man Group plc increased its stake in Oscar Health by 344.8% in the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after purchasing an additional 1,405,554 shares in the last quarter. Toronto Dominion Bank bought a new stake in Oscar Health in the fourth quarter valued at $1,008,000. Finally, Concurrent Investment Advisors LLC acquired a new position in shares of Oscar Health during the first quarter valued at about $677,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.